Alchemab Therapeutics has entered into a licensing agreement with Eli Lilly and Company (Lilly) for ATLX-1282, Alchemab’s ...

Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an expanded access program (EAP) ...

Reduced levels of a critical protein are linked to devastating brain diseases like Alzheimer's, frontotemporal dementia, and amyotrophic lateral sclerosis (ALS). Surprisingly, the protein shortage ...

Beyond Wilson's dominance, the 2025 ACM Awards were packed with celebration. Earlier, first-time and leading nominee Ella ...

As we move deeper into may, the East Texas harvest season will begin to show, whether its a bumper crop or a ‘break even’ season.

Late last year, the therapy developers dosed their first patient following positive preclinical data demonstrating safety and ...

Amyotrophic lateral sclerosis (ALS) – known as Lou Gehrig’s Disease based on the iconic 1930s New York Yankee baseball player ...

Jeffrey Lee Sharp, 62, faced trial on Monday in Judge R. Scott McKee’s courtroom and was convicted by a jury on Tuesday despite pleading not guilty.

Coya Therapeutics, Inc.’s COYA share price has surged by 12.31%, which has investors questioning if this is right time to ...